Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Prelude Therapeutics Inc Director's Dealing 2021

Jul 21, 2021

34339_dirs_2021-07-20_1615f932-57e9-471e-aa38-7731ec2769be.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Prelude Therapeutics Inc (PRLD)
CIK: 0001678660
Period of Report: 2021-07-19

Reporting Person: Babler Martin (Director)

More from Prelude Therapeutics Inc

Interim / Quarterly Report 2026
May 12
Regulatory Filings 2026
May 12
Regulatory Filings 2026
Apr 20
Regulatory Filings 2026
Apr 15
Director's Dealing 2026
Mar 20
Major Shareholding Notification 2026
Feb 13
Director's Dealing 2026
Feb 5
Director's Dealing 2026
Feb 5
Director's Dealing 2026
Feb 5
Director's Dealing 2026
Feb 5
View all filings →